Despite the fourth-quarter shortfall, Tandem Diabetes provided an optimistic revenue outlook for the fiscal year 2024, projecting non-GAAP sales to be approximately $850 million, which is above the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback